Obsidian Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-08. The offering totals $49.9M, of which $32.4M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Peter Barrett | Director | Palo Alto, CA |
| Jason Gardner | Director | EMERYVILLE, CA |
| Michael Gilman | Director | Waltham, MA |
| Karen Hong | Director | Princeton, NJ |
| Carolyn Ng | Director | Cambridge, MA |
| Peter Barrett | Executive Officer | Palo Alto, CA |
| Michael Gilman | Executive Officer | Waltham, MA |
| David Neafus | Executive Officer | Walpole, MA |